Geratherm Medical AG (ETR:GME)
2.670
+0.020 (0.75%)
Aug 5, 2026, 5:35 PM CET
Geratherm Medical AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 7.61 | 7.68 | 5.24 | 8.74 | 2.26 |
Short-Term Investments | - | 1.97 | 2.51 | 2.15 | 4.21 |
Cash & Short-Term Investments | 7.61 | 9.64 | 7.74 | 10.89 | 6.47 |
Cash Growth | -21.12% | 24.52% | -28.85% | 68.25% | -36.95% |
Accounts Receivable | 1.26 | 1.19 | 1.81 | 3.78 | 3.18 |
Other Receivables | - | - | - | - | 0.91 |
Total Trade Receivables | 1.26 | 1.19 | 1.81 | 3.78 | 4.08 |
Inventory | 3.63 | 5.56 | 9.36 | 7.03 | 8.54 |
Other Current Assets | 2.39 | 2.13 | 2.1 | 1.86 | 0.52 |
Total Current Assets | 16.4 | 18.39 | 20.88 | 23.32 | 19.61 |
Net Property, Plant & Equipment | 6.98 | 7.67 | 9.45 | 9.99 | 9.32 |
Other Intangible Assets | 1.73 | 1.61 | 4.56 | 4.14 | 4.07 |
Goodwill | - | 0 | 0.07 | 0.08 | 0.09 |
Long-Term Investments | 0.73 | 0.73 | 0.63 | 0.63 | 1.37 |
Other Long-Term Assets | - | - | - | - | 0.1 |
Total Assets | 26 | 28.54 | 35.72 | 38.38 | 34.56 |
Accounts Payable | 0.67 | 0.8 | 0.85 | 1.51 | 1.43 |
Accrued Expenses | 0.59 | 0.66 | 0.83 | 0.96 | 0.04 |
Short-Term Debt | - | - | - | - | 2.84 |
Current Portion of Leases | - | - | - | - | 0.28 |
Unearned Revenue | - | - | - | - | 1.76 |
Other Current Liabilities | 1.9 | 1.8 | 2.11 | 2.17 | 2.07 |
Total Current Liabilities | 3.16 | 3.25 | 3.79 | 4.64 | 8.43 |
Long-Term Debt | 2.48 | 3.28 | 7.23 | 9.29 | 5.49 |
Long-Term Leases | - | - | - | - | 0.25 |
Other Long-Term Liabilities | 0.91 | 1.18 | 2.09 | 2.22 | 1.76 |
Total Long-Term Liabilities | 3.39 | 4.46 | 9.32 | 11.51 | 7.5 |
Total Liabilities | 5.04 | 5.79 | 10.13 | 12.84 | 15.93 |
Common Stock | 5.41 | 5.41 | 5.41 | 5.44 | 4.95 |
Additional Paid-in Capital | 15.16 | 15.16 | 16.76 | 16.96 | 12.2 |
Accumulated Other Comprehensive Income | 0.64 | 0.65 | 0.53 | - | - |
Retained Earnings | -1.56 | -0.2 | -0.37 | -0.07 | 1.37 |
Total Common Shareholders' Equity | 19.66 | 21.02 | 22.33 | 22.34 | 18.52 |
Minority Interest | -0.21 | -0.2 | 0.28 | -0.11 | 0.11 |
Shareholders' Equity | 19.45 | 20.82 | 22.61 | 22.23 | 18.63 |
Total Liabilities & Equity | 26 | 28.54 | 35.72 | 38.38 | 34.56 |
Total Debt | 2.48 | 3.28 | 7.23 | 9.29 | 8.86 |
Net Cash (Debt) | 5.13 | 6.37 | 0.51 | 1.59 | -2.39 |
Net Cash Growth | -19.40% | 1138.95% | -67.71% | - | - |
Net Cash Per Share | 0.95 | 1.18 | 0.10 | 0.29 | -0.48 |
Book Value | 19.66 | 21.02 | 22.33 | 22.34 | 18.52 |
Book Value Per Share | 3.63 | 3.88 | 4.13 | 4.10 | 3.74 |
Tangible Book Value | 17.93 | 19.41 | 17.7 | 18.12 | 14.36 |
Tangible Book Value Per Share | 3.31 | 3.59 | 3.27 | 3.33 | 2.90 |